Trial met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups - ...

Dr. Simon Plyte, Biomunex's CSO, has been invited to present MAIT engagers preclinical data during an oral communication at 2025 SITC Annual meeting With a very attractive safety and efficacy ...

March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that interim clinical data from its ...

Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells co-exp ...

Third quarter 2025 net revenue was $118.8 million, up slightly compared to $118.6 million in the third quarter of 2024, fueled by the timing of Rejuvenate 2.0 shipments and the continued expansion of ...

Anika Therapeutics, Inc. (NASDAQ: ANIK) Q3 2025 Earnings Call Transcript November 5, 2025 Anika Therapeutics, Inc. misses on ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...

AI use of campus continues to grow with DenAI and LLM based courses As the use and development of artificial intelligence continues to increase, students and faculty have become more involved with the ...

Many students and parents have complained that schools are not sharing Class 11 registration numbers required for the ...

This updated syllabus aims to provide a deeper understanding of business concepts, management principles, and real-world ...

Joel Klatt previews and makes his picks for Week 11 of college football, including the top-10 BYU-Texas Tech matchup.

US stocks tumbled on Tuesday as doubts about high-running AI valuations preyed on investors sifting through the latest flurry of quarterly earnings, who received a fresh warning from top CEOs.